Transcatheter Aortic Valve Replacement Associated With Fibrin-Associated Large B-Cell Lymphoma
Ajit K Tharakan1, Adam Hoffhines2, Laura Brett3
1Oklahoma Heart Institute, Tulsa, Oklahoma, USA.
JACC. Case reports
|December 12, 2025
まとめ
Fibrin-associated large B-cell lymphoma (FA-LBCL) is a rare cause of transcatheter aortic valve failure. This case report details FA-LBCL as the primary cause of structural valve degeneration, highlighting its role in premature valve failure.
科学分野:
- Cardiology
- Oncology
- Pathology
背景:
- Fibrin-associated large B-cell lymphoma (FA-LBCL) is a rare neoplastic disorder.
- The role of FA-LBCL in transcatheter valve failure was previously unknown.
- This report details the first case of FA-LBCL in a transcatheter aortic valve.
研究 の 目的:
- To report the first case of FA-LBCL causing structural valve degeneration (SVD) in a transcatheter aortic valve.
- To establish neoplastic processes as a cause of SVD in transcatheter valves.
- To emphasize the importance of considering FA-LBCL in the differential diagnosis of transcatheter aortic valve replacement failure.
主な方法:
- Case presentation of a 62-year-old man with a history of transcatheter aortic valve replacement.
- Histopathologic analysis of the explanted aortic valve.
- Diagnosis of FA-LBCL as the primary cause of valve failure.
主要な成果:
- FA-LBCL was identified as the cause of structural valve degeneration in a transcatheter aortic bioprosthetic valve.
- This represents the first documented instance of FA-LBCL causing SVD in such a device.
- Surgical explantation proved both diagnostic and curative for the patient.
結論:
- FA-LBCL is a potential cause of structural valve degeneration in transcatheter bioprosthetic valves.
- FA-LBCL should be included in the differential diagnosis for premature transcatheter valve failure.
- Early consideration of FA-LBCL can lead to timely diagnosis and effective treatment.

